EFFICACY AND SAFETY OF UPADACITINIB FOR ATOPIC DERMATITIS IN DUPILUMAB NON-RESPONDERS: A MULTICENTER RETROSPECTIVE STUDY

被引：0
|
作者：
Georgakopoulos, Jorge R. [1 ]
Sheka, Dropen [2 ]
Rankin, Brian [3 ]
Maliyar, Khalad [1 ]
Rimke, Alexander [4 ]
Prajapati, Vimal H. [3 ]
Yeung, Jensen [1 ]
机构：
[1] Univ Toronto, Div Dermatol, Dept Med, Toronto, ON, Canada
[2] Univ Toronto, Fac Med, Toronto, ON, Canada
[3] Univ Calgary, Div Dermatol, Dept Med, Calgary, AB, Canada
[4] Dermatol Res Inst, Calgary, AB, Canada
来源：
ACTA DERMATO-VENEREOLOGICA | 2023年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
OL.12
引用
收藏
页码：16 / 16
页数：1
相关论文
共 50 条
  • [21] Management Recommendations for Dupilumab Partial and Non-durable Responders in Atopic Dermatitis
    Aleksi J. Hendricks
    Peter A. Lio
    Vivian Y. Shi
    American Journal of Clinical Dermatology, 2019, 20 : 565 - 569
  • [22] Upadacitinib outperforms dupilumab in restoring the fungal microbiome in atopic dermatitis
    Li, Tingting
    Tao, Rong
    Yang, Li
    Wan, Zhe
    Li, Ruoyu
    Wang, Ruojun
    BRITISH JOURNAL OF DERMATOLOGY, 2025,
  • [23] Efficacy and safety of upadacitinib vs dupilumab treatment for moderate to severe atopic dermatitis in four body regions - Analysis from the Heads Up Study
    Thyssen, Jacob P.
    Rosmarin, David
    Costanzo, Antonio
    Warren, Richard B.
    Ladizinkski, Barry
    Hu, Xiaofei
    Nduaka, Chudi
    Vigna, Namita
    Armstrong, April
    CLINICAL AND EXPERIMENTAL ALLERGY, 2022, 52 (08): : 998 - 999
  • [24] 52-week evaluation of the efficacy of dupilumab for moderate to severe atopic dermatitis in clinical practice: A Canadian multicenter retrospective study
    Jo, Christine E.
    Georgakopoulos, Jorge R.
    Ladda, Matthew
    Ighani, Arvin
    Drucker, Aaron
    Mufti, Asfandyar
    Yeung, Jensen
    Piguet, Vincent
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB35 - AB35
  • [25] Efficacy and Safety of Dupilumab in Chinese Patients With Atopic Dermatitis: A Real-World Study
    Zhou, Bingjing
    Peng, Cong
    Li, Liqiao
    Liu, Runqiu
    Zhu, Lei
    Chen, Xiang
    Li, Jie
    FRONTIERS IN MEDICINE, 2022, 9
  • [26] Real-life efficacy and safety of upadacitinib in adolescents with moderate-to-severe atopic dermatitis unresponsive to dupilumab: A case series
    Patruno, Cataldo
    Fabbrocini, Gabriella
    Potestio, Luca
    Genco, Lucia
    Napolitano, Maddalena
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (07) : E901 - E903
  • [27] Predictive factors for responders to upadacitinib treatment in patients with atopic dermatitis
    Hagino, Teppei
    Yoshida, Mai
    Hamada, Risa
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [28] Assessment of the efficacy and safety of dupilumab combined with cyclosporine A in patients with atopic dermatitis
    Liu, Xiaotao
    Wang, Lifeng
    Zheng, Lingling
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2023, 22 (07) : 1463 - 1468
  • [29] Efficacy and Safety of Upadacitinib versus Dupilumab Treatment for Moderate-to-Severe Atopic Dermatitis in Four Body Regions: Analysis from the Heads Up Study
    Thyssen, Jacob P.
    Rosmarin, David
    Costanzo, Antonio
    Warren, Richard
    Chu, Chia-Yu
    Chovatiya, Raj
    Ladizinski, Barry
    Hu, Xiaofei
    Liu, Yingyi
    Calimlim, Brian
    Nduaka, Chudi
    Vigna, Namita
    Armstrong, April
    DERMATOLOGY, 2025, 241 (01) : 10 - 18
  • [30] Efficacy of Dupilumab for Atopic Dermatitis According to Clinical Course and Clinical Findings: A Multicentre Retrospective Study
    Nakahara, Takeshi
    Kido-Nakahara, Makiko
    Onozuka, Daisuke
    Sakai, Sawako
    Hirose, Tomoko
    Take, Nobutoshi
    Sugiyama, Akiko
    Harada, Kayo
    Tsuji, Gaku
    Kikuchi, Satoko
    Kohda, Futoshi
    ACTA DERMATO-VENEREOLOGICA, 2021, 101
12345